Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004303647 | SCV003959021 | uncertain significance | not specified | 2023-03-28 | criteria provided, single submitter | clinical testing | The c.598T>C (p.Y200H) alteration is located in exon 2 (coding exon 1) of the B3GALT2 gene. This alteration results from a T to C substitution at nucleotide position 598, causing the tyrosine (Y) at amino acid position 200 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |